US Stock MarketDetailed Quotes

ROIV Roivant Sciences

Watchlist
  • 11.570
  • +0.070+0.61%
Close Dec 20 16:00 ET
  • 11.559
  • -0.011-0.10%
Post 20:01 ET
8.42BMarket Cap1.98P/E (TTM)

About Roivant Sciences Company

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Company Profile

SymbolROIV
Company NameRoivant Sciences
Listing DateDec 14, 2020
Founded2021
CEOMr. Matthew Gline
MarketNASDAQ
Employees908
Fiscal Year Ends03-31
Address50 Broadway,7th Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeSW1H 0BD
Phone44-207-400-3347
Websitehttp://www.roivant.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew Gline
  • Chief Executive Officer and Director
  • 738.19K
  • Dr. Eric Venker, M.D.,Pharm.D.
  • President and Chief Operating Officer
  • --
  • Rakhi Kumar
  • Chief Accounting Officer
  • 4.33M
  • Richard Pulik
  • Chief Financial Officer
  • 5.15M
  • Dr. Mayukh Sukhatme
  • President, Chief Investment Officer and Director
  • 574.56K
  • Ilan Oren
  • Chairman of the Board
  • 488.49K
  • Melissa B. Epperly
  • Independent Director
  • 444.24K
  • Meghan M. Fitzgerald, Ph.
  • Independent Director
  • 941.68K
  • Keith Manchester, M.D.
  • Independent Director
  • 442.59K
  • James C. Momtazee
  • Independent Director
  • 459.24K
  • Daniel Gold
  • Independent Director
  • 449.24K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List